UROGEN PHARMA LTD.

(URGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about UROGEN PHARMA LTD.
11:01aUroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
AQ
05/16UroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
BU
05/16UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
AQ
05/13UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
BU
05/10TRANSCRIPT : UroGen Pharma Ltd., Q1 2022 Earnings Call, May 10, 2022
CI
05/10UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Develop..
BU
05/10UroGen Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10Earnings Flash (URGN) UROGEN PHARMA Posts Q1 Loss $-1.25, vs. Street Est of $-1.25
MT
05/10Earnings Flash (URGN) UROGEN PHARMA Posts Q1 Revenue $13.6M, vs. Street Est of $15.2M
MT
05/10UroGen Pharma Ltd. Provides Revenue Guidance for the Full Year 2022
CI
05/03UroGen Pharma to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
BU
04/27Berenberg Bank Initiates Coverage on UroGen Pharma With Buy Rating, $20 Price Target
MT
04/26Oppenheimer Adjusts UroGen Pharma Price Target to $21 From $30, Maintains Outperform Ra..
MT
03/29UroGen Pharma Says It Secured FDA Clearance for Phase 1 Trial of Investigational Bladde..
MT
03/29UroGen Announces FDA Clearance of IND Application for the Investigational Immunotherapy..
BU
More most relevant news
All news about UROGEN PHARMA LTD.
11:01aUroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
AQ
05/16UroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
BU
05/16UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
AQ
05/13UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
BU
05/10TRANSCRIPT : UroGen Pharma Ltd., Q1 2022 Earnings Call, May 10, 2022
CI
05/10UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Develop..
BU
05/10UROGEN PHARMA LTD. Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/10UroGen Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10Earnings Flash (URGN) UROGEN PHARMA Posts Q1 Loss $-1.25, vs. Street Est of $-1.25
MT
05/10Earnings Flash (URGN) UROGEN PHARMA Posts Q1 Revenue $13.6M, vs. Street Est of $15.2M
MT
More news
News in other languages on UROGEN PHARMA LTD.
05/10UroGen Pharma Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
05/10Earnings Flash (URGN) UROGEN PHARMA affiche un chiffre d'affaires de 13,6 millions de d..
05/10UroGen Pharma Ltd. fournit des prévisions de revenus pour l'ensemble de l'année 2022
03/29UroGen Pharma annonce l'approbation par la FDA de la demande de IND pour l'immunothérap..
03/22Phathom Pharmaceuticals nomme Molly Henderson directrice financière et commerciale
03/21UroGen Pharma Ltd. annonce ses résultats pour le quatrième trimestre clos le 31 décembr..
03/21Earnings Flash (URGN) UROGEN PHARMA affiche un revenu de 16,2 millions de dollars pour ..
03/21UroGen Pharma Ltd. annonce ses résultats pour l'année complète se terminant le 31 décem..
03/01UroGen Pharma dépose une demande de nouveau médicament auprès de la FDA américaine pour..
03/01Urogen Pharma Ltd. Soumission d'une demande d'autorisation de mise sur le marché d'un n..
More news
Analyst Recommendations on UROGEN PHARMA LTD.
04/27Berenberg Bank Initiates Coverage on UroGen Pharma With Buy Rating, $20 Price Target
MT
04/26Oppenheimer Adjusts UroGen Pharma Price Target to $21 From $30, Maintains Outperform Ra..
MT
03/22Goldman Sachs Adjusts UroGen Pharma's Price Target to $11 from $10, Maintains Neutral R..
MT
03/22HC Wainwright Adjusts UroGen Pharma's Price Target to $26 From $34, Reiterates Buy Rati..
MT
01/18HC Wainwright Adjusts UroGen Pharma's Price Target to $34 From $50, Reiterates Buy Rati..
MT
More recommendations
Press releases
11:01aUroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
AQ
05/16UroGen Highlights New Data Presented at AUA that Adds to the Evidence Supporting In-Off..
BU
05/16UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
AQ
05/13UroGen Pharma Highlights Data Presentations at the 2022 American Urological Association..
BU
05/10UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Develop..
BU
More press releases
Upcoming event on UROGEN PHARMA LTD.